Sugase T, Kanemura T, Matsuura N, Sugimura K, et al. Clinical outcomes of pembrolizumab plus chemotherapy for postoperative recurrent esophageal squamous cell carcinoma. Dis Esophagus 2025;38:doaf029.
PMID: 40448400